These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17344346)

  • 1. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
    Lovrich SD; La Fleur RL; Jobe DA; Johnson JC; Asp KE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2007 May; 14(5):635-7. PubMed ID: 17344346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
    Jobe DA; Lovrich SD; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
    Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
    Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
    Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody responses to Borrelia burgdorferi outer surface proteins C and F in experimentally infected Beagle dogs.
    Callister SM; LaFleur RL; Jobe DA; Lovrich SD; Wasmoen TL
    J Vet Diagn Invest; 2015 Jul; 27(4):526-30. PubMed ID: 26069225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Borrelia burgdorferi outer surface protein antibodies in wild white-tailed deer (Odocoileus virginianus) in New York and Pennsylvania, USA.
    Kirchgessner MS; Freer H; Whipps CM; Wagner B
    Vet Immunol Immunopathol; 2013 May; 153(1-2):165-9. PubMed ID: 23507438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL; Thueson RK; Uriona TJ
    J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
    Earnhart CG; Buckles EL; Dumler JS; Marconi RT
    Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.
    Camire AC; Hatke AL; King VL; Millership J; Ritter DM; Sobell N; Weber A; Marconi RT
    Vet J; 2021 Jul; 273():105676. PubMed ID: 34148599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.